An essential role for dendritic cells in vernal keratoconjunctivitis: analysis by laser scanning confocal microscopy

M Liu1, H Gao, T Wang

  • 1Shandong Eye Hospital, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao, China.

Insights

Dendritic cells (DCs) are elevated in vernal keratoconjunctivitis (VKC) patients. Treatment reduced DC density, suggesting DCs are a therapeutic target for VKC.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Vernal keratoconjunctivitis (VKC) pathogenesis involves CD4+ T helper type 2 cells and antigen-presenting cells.
  • Dendritic cells (DCs) are crucial antigen-presenting cells implicated in VKC.
  • This study investigates the density, distribution, and morphology of DCs in VKC patients using in vivo confocal microscopy.

Purpose of the Study:

  • To survey the density, distribution, and morphology of dendritic cells (DCs) in patients with vernal keratoconjunctivitis (VKC).
  • To evaluate the dynamic changes in DCs following treatment for VKC.

Main Methods:

  • In vivo confocal microscopy was used to examine 35 VKC patients and 35 age-matched controls.
  • DC density, morphology, and distribution were assessed before and at 1, 3, and 6 months after treatment with fluorometholone and cyclosporine A eye drops.
  • Age differences between VKC and control groups were statistically significant.

Main Results:

  • VKC patients exhibited significantly higher DC densities in the bulbar conjunctiva, limbus, and peripheral cornea compared to controls.
  • Treatment led to a significant decrease in DC density at the conjunctiva by 3 months.
  • DC densities at the limbus and peripheral cornea also decreased significantly post-treatment but remained higher than controls.

Conclusions:

  • In vivo confocal microscopy is effective for monitoring dynamic changes of DCs in VKC.
  • Dendritic cells play a critical role in VKC.
  • DCs represent a potential therapeutic target for managing VKC.
Abstract